CAS No. 1051375-16-6
| IUPAC Name | (3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide | |
|---|---|---|
| CAS Number | 1051375-16-6 | |
| Molecular Formula |
C20H19F2N3O5 |
|
| Molecular Weight (MW) | 419.38 | |
| SMILES | CC1CCOC2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O | |
| InChIKey | RHWKPHLQXYSBKR-BMIGLBTASA-N |
Dolutegravir (GSK1349572) is a potent, two-metal-binding HIV integrase inhibitor that inhibits HIV-1 integrase strand transfer with an IC50 ofin a cell-free assay. In peripheral blood mononuclear cells, it suppresses HIV-1 replication with an IC50 of. By blocking viral DNA integration into the host genome, dolutegravir retains activity against raltegravir-resistant mutant strains, demonstrating a high barrier to resistance and preventing viral replication. [1]
|
Concentration
Volume
Mass
|
|---|
| Solvent | Solubility & Note |
|---|---|
| DMSO |
83 mg/mL
(197.91 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
83 mg/mL
(197.91 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(200.29 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(200.29 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
| DMSO |
84 mg/mL
(200.29 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO. The recommended stock concentration is 10 mM in DMSO.) |
| Water | Insoluble |
| Ethanol | Insoluble |
- Preheat media/saline to 37°C.
- Mix rapidly (pipette/vortex) upon addition.
- For complex mixes, always add the aqueous phase last.
- Re-dissolve minor precipitates with a 37°C water bath and sonication (≤30 min).
Pre-aliquoted for Longevity: Solid-state aliquots offer significantly longer shelf life compared to stock solutions, ensuring maximum stability for every use.
Looking for a specific aliquot size? Reach out to your local sales representative or contact us at orders@selleckchem.com.
- GSK1349572 (Dolutegravir) Mechanism of Action: HIV-1 Integrase Inhibition in CD4+ T Cell Research
- GSK1349572 (Dolutegravir) Clinical Trials
- GSK1349572 (Dolutegravir): Selectivity & Specificity
- GSK1349572 (Dolutegravir) Working Concentration | Cell Culture | Treatment
- GSK1349572 (Dolutegravir) Solubility in DMSO
- GSK1349572 (Dolutegravir) Stock Solution
- GSK1349572 (Dolutegravir) Storage
- GSK1349572 (Dolutegravir) Stability
- GSK1349572 (Dolutegravir) Combination Database
- GSK1349572 (Dolutegravir) Molecular Weight
- GSK1349572 (Dolutegravir) SMILES
- GSK1349572 (Dolutegravir) Chemical Structure (2D and 3D)
- GSK1349572 (Dolutegravir) IC50 for Cell-based and Cell-free Assays
- GSK1349572 (Dolutegravir) Sigma (SBR00080)? Try a better option.
- GSK1349572 (Dolutegravir) MedChemExpress (HY-13238)? Try a better option.
- GSK1349572 (Dolutegravir) Cayman (22191)? Try a better option.
- GSK1349572 (Dolutegravir) APExBIO (A4074)? Try a better option.
- GSK1349572 (Dolutegravir) SDS|MSDS